ERBB2 and neoplasm: A higher percentage of tumours from the triple‐negative (SR‐/HER2‐) sub‐group displayed decreased or deficient Numb expression compared with those in the other sub‐groups (44% [11/25] of the basal‐like triple‐negative cell line).18